Investigating how NKX3.1 affects prostate cancer as men age

Nuclear and non-nuclear functions of NKX3.1 in suppression of prostate cancer

NIH-funded research Columbia University Health Sciences · NIH-11106221

This study is looking at how a gene called NKX3.1 affects the growth of prostate cancer in older men, especially by exploring its new roles outside the cell's nucleus, and it hopes to find ways to improve treatment options for patients as they age.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11106221 on NIH RePORTER

What this research studies

This research focuses on understanding how the NKX3.1 gene influences the progression of prostate cancer, particularly in older men. It examines both the traditional nuclear functions of NKX3.1 and its newly discovered roles outside the nucleus, especially under stress conditions. By studying mouse models, the research aims to uncover how the loss of NKX3.1 and associated mitochondrial mutations contribute to faster cancer progression. Patients may benefit from insights into how aging impacts prostate cancer and potential new therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are older men who are at risk for or currently have prostate cancer.

Not a fit: Patients with prostate cancer who are not aging or those with early-stage disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing or treating prostate cancer in aging men.

How similar studies have performed: Previous research has shown promising results in understanding the role of genetic factors in cancer progression, suggesting that this approach could yield valuable insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions advanced prostate cancercancer progressionCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.